ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.44282
2.66%
Brent Oil
80.94
0.17%
Bitcoin
69,064.73
1.94%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
03/06/202405:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:KGEIKolibri Global Energy Inc
03/06/202405:45Business WireLindsay Announces Irrigation Project Valued at More Than $100 MillionNYSE:LNNLindsay Corporation
03/06/202405:45Business WireThe Estée Lauder Companies Completes Acquisition of DECIEMNYSE:ELEstee Lauder Companies Inc
03/06/202405:45Business WireKolibri Global Energy Inc. Announces Nickel Hill Production Rates and Inclusion in Russell IndexTSX:KEIKolibri Global Energy Inc
03/06/202405:45Business WireFerguson plc ("Company"): Total Voting RightsNYSE:FERGFerguson Plc
03/06/202405:45Business WireWard Dickson Appointed to Avery Dennison Board of DirectorsNYSE:AVYAvery Dennison Corp
03/06/202405:45Business WireTakeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to PlaceboNYSE:TAKTakeda Pharmaceutical Company Ltd
03/06/202405:41Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNYSE:HASIHannon Armstrong Sustainable Infrastructure Capital Inc
03/06/202405:39PR Newswire (US)SHEIN Launches SHEIN Exchange Resale Platform in Europe and the United Kingdom
03/06/202405:38Edgar (US Regulatory)Form 8-K - Current reportNYSE:EWEdwards Lifesciences Corp
03/06/202405:37Alliance NewsAlliance NewsSpringfield Properties to partner with Barratt to develop DurieshillLSE:SPRSpringfield Properties Plc
03/06/202405:37PR Newswire (US)Nereus Finance Integrates LI.FI To Enable Seamless Onboarding
03/06/202405:36NEWSBTCNotcoin Unstoppable! Token Soars Over 400%, Blazes New All-Time HighCOIN:TRXUSDTRON
03/06/202405:35GlobeNewswire Inc.Transactions in connection with share buyback programme
03/06/202405:34Business WireDefiniGEN and Atelerix Collaborate to Ship In Vitro Cell Models Internationally Without the Need for Freezing or Cryopreservation
03/06/202405:33Edgar (US Regulatory)Form SD - Specialized disclosure reportNYSE:LXFRLuxfer Holdings PLC
03/06/202405:30Business WireEdwards Lifesciences to Sell Critical Care to BDNYSE:EWEdwards Lifesciences Corp
03/06/202405:30GlobeNewswire Inc.Agios Announces Phase 3 ENERGIZE-T Study of Mitapivat Met Primary Endpoint and All Key Secondary Endpoints in Adults with Transfusion-Dependent Alpha- or Beta-ThalassemiaNASDAQ:AGIOAgios Pharmaceuticals Inc
03/06/202405:30Business WireBabcock & Wilcox Signs Agreement to Proceed with Work for Coal-to-Biomass Power Plant Conversion and Carbon Capture Project in MichiganNYSE:BWBabcock and Wilcox Enterprises Inc
03/06/202405:30Business WireChatham Lodging Trust Provides Business UpdateNYSE:CLDTChatham Lodging Trust
03/06/202405:30Business WireHyatt’s Growth Momentum Continues With Record Global Pipeline of 129,000 RoomsNYSE:HHyatt Hotels Corporation
03/06/202405:30Business WireKalVista Pharmaceuticals Presents Data on Persisting Unmet Needs in Hereditary Angioedema at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024NASDAQ:KALVKalVista Pharmaceuticals Inc
03/06/202405:30Business WireAult Alliance Announces Plans to Issue a Special Preferred Artificial Intelligence Data Center and Bitcoin Mining Dividend to StockholdersAMEX:AULTAult Alliance Inc
03/06/202405:30PR Newswire (Canada)/R E P R I S E --Décès de M. Raphael André - Reprise des audiences le 3 juin 2024/
03/06/202405:30PR Newswire (Canada)Denison Announces Completion of Inaugural ISR Field Test Program at MidwestAMEX:DNNDenison Mines Corp
03/06/202405:30PR Newswire (US)Sustainable Fuel Market worth $299.9 billion | MarketsandMarkets™
03/06/202405:30PR Newswire (US)AZZ Inc. Appoints Jason Crawford as Chief Financial OfficerNYSE:AZZAZZ Inc
03/06/202405:30PR Newswire (US)BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology LeaderNYSE:BDXBecton Dickinson and Company
03/06/202405:30PR Newswire (US)Organizations With Network Observability Are 3.5X More Likely to Significantly Reduce Detection Times, VIAVI Study RevealsNASDAQ:VIAVViavi Solutions Inc
03/06/202405:30PR Newswire (US)HYSTER-YALE, INC. AND HYSTER-YALE MATERIALS HANDLING, INC. UNVEIL NEW LOGOS AS NAME CHANGES GO INTO EFFECTNYSE:HYHyster Yale Materials Handling Inc

Su Consulta Reciente

EU
SGHJ
Societe Generale SA Nts ...
NASDAQ
ABBIAXX
Hsbc Bank Usa Na Capped ...
EU
FRSG00014CL4
SG Issuer Sg Issuer Zc O...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados